Treatment of infected hip arthroplasty. Retrospective study;Tratamiento de la artroplastia infectada de cadera. Estudio retrospectivo

Revista de Ortopedia y Traumatologia

Volumn 43, Issue 2, 1999, Pages 84-92

  Ladero Morales, F ^a,b   Fernandez Gonzalez J ^a   Blanco Ortiz, F ^a   Martinez Martin J ^a   Garcia Araujo C ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE   (Spain)

Author keywords

Arthroplasty; Hip; Infection

Indexed keywords

ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; DEBRIDEMENT; FOLLOW UP; FUNCTIONAL ASSESSMENT; GRAFT INFECTION; HIP ARTHROPLASTY; HOSPITAL INFECTION; INFECTION; INFECTION RISK; PATIENT SATISFACTION; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY;

EID: 0032953921     PISSN: 04825985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Aalto, K; Österman, K; Peltola, H y Räsänen, J: Changes in erythrocyte sedimentarion rate and C-reactive protein after total hip arthroplasty. Clin Orthop, 184: 118-120, 1984.
2. Ahlgren, SA; Gudmundsson, G y Bartholdsson, E: Function after removal of a septic total hip prosthesis. A survey of 27 Girdlestone hips. Acta Orthop Scand, 51: 541-545, 1980.
3. Ainscow, DAP, y Denham, RA: The risk of haematogenous infection in total hip replacements. J Bone Joint Surg, 66B: 580-582, 1984.
4. Balderstone, RA: Treatment of the septic hip with total hip arthroplasty. Clin Orthop, 221: 231-237, 1987
5. Barrack, RL, y Harris, WH: The value of aspiration of the hip joint before revision total hip arthroplasty. J Bone Joint Surg, 75A: 66-76, 1993
6. Benediktosdottir, E: Non-sporeforming anaerobic bacteria in clean surgical wounds - air and skin contamination. J Hosp Infect, 5: 38-49, 1984.
7. Boubaker, A; Delaloye, AB, y Blanc, CH: Inmunoscintigraphy with antigranulocyte monoclonal antibodies for the diagnosis of septic loosening of hip prosthesis. Eur J Nucl Med, 22: 139-147, 1995.
8. Bourne, RB; Hunter, GA; Rorabeck, CH, y Macnab, JJ: A six year follow-up of infected total hip replacements managed by Girdlestone's arthroplasty. J Bone Joint Surg, 66B: 340-343, 1984.
9. Boyd, RJ: A double blind clinical trial of prophylactic antibiotics in hip fracture J Bone Joint Surg, 55A: 1251-1259, 1973.
10. Brown, WJ: Microbiology of the infected total joint arroplasty. Sem Arthroplasty, 5: 107-113, 1994.
11. Buchholz, HW; Elson, RA; Engelbrecht, E; Lodenkämper, H; Röttger, J, y Siegel, A: Management of deep infection of total hip replacement. J Bone Joint Surg, 63B: 342-353, 1981.
12. Callaghan, JJ; Salvati, EA; Brause, BD; Rimnac, CM, y Wright, TM: Reimplantation for salvage of the infected hip: Rationale for the use of gentamicin-impregnated cement and beads. The hip: Procs of 13th Scientific Meeting of the hip Society, St Louis, 1985, 65-94.
13. Canner, GC: The infected hip after total hip arroplasty. J Bone Joint Surg. 66A: 1393-1399, 1984.
14. Carlsson, AS: Prophylactic antibiotics against early and late infections after total hip replacement. Acta Orthop Scand, 48; 405-410, 1977.
15. Carlsson, AS: Revision with gentamicin-impregnated cement for deep infections, in total hip arthroplasties. J Bone Joint Surg, 60A: 1059-1064, 1978.
16. Charnley, J: A sterile-air operating theatre enclosure. Br J Surgery, 51: 195-202, 1964.
17. Charnley, J: Postoperative infection after total hip arthroplasty with special reference to air contamination in the operative room. Clin Orthop, 87: 167-187, 1972.
18. Chemey, DL, y Amstutz, HC: Total hip replacement in the previously septic hip. J Bone Joint Surg, 65A: 1256-1265, 1983.
19. Covey, D, y Albright, JA: Current concepts review. Clinical significance of the erythrocyte sedimentabon rate in orthopedic surgery. J Bone Joint Surg, 69A: 148-151, 1987.
20. Davies, AJ; Lockley, RM; Jones, A; el-Safty, M, y Clothier, JC: Comparative pharmacokinebcs of cefamandole, cefuroxime and cephradine during total hip replacement. J Antimicrob Chemoher, 17: 637-640, 1986.
21. Doyon, F; Evrard, L, y Mazas, F: An assessment of published trials on antibiotic prophylaxis in orthopedic surgery. Frech J Orthop Surg, 3: 49-53, 1989.
22. Drancourt, M; Stein, A, y Arfenson, JN: Oral rifampin plus ofloxacin for treatment of staphylococcus-infected orthopedic implants. Antimicrob Agents Chemothe. 37: 1214-1218, 1993.
23. Duncan, CP, y Marsi, BA: The role of antibiotic loaded cement in the treatment of and infection after total hip replacement. J Bone Joint Surg, 76A: 1742-1751, 1994.
24. Elson, RA: Exchange arthroplasty for infection. Prespectives from the United Kingdom. Clin Orthop, 24: 761-767, 1993.
25. Elson, RA: One-stage exchange in the treatment of the infected total hip arthroplasty. Sem Arthroplasty, 5: 137-141, 1994.
26. Ericson, C: Cloxacilin in the prophylaxis of postoperative infections of the hip. J Bone Joint Surg. 5A: 808-813, 1973.
27. Estrada, R; Tsukayama, D, y Gustilo, R: Management of THA infections. A prospective study of 108 cases. Orthop Trans, 17: 1114-1115, 1994.
28. Evrard, J: Les infections des protheses totales de hanche. Rev Rhum, 53: 109-112, 1986.
29. Fitzgerald, RH: Hip implant infection Treatment with resection arthroplasty and late total hip arthroplasty. Am J Med, 78 (suppl 6B): 225-228, 1985.
30. Fitzgerald, RH: Problems associated with the infected total hip arthroplasty. Clin Rheum Dis, 12: 537-554, 1986.
31. Fitzgerald, RH; Nolan, DR; Ilstrup, DM; Van Scoy, RE; Washintong, JA, y Coventry, MB: Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg, 59A: 847-855, 1977
32. Garvin, KL, y Haussen, AD: Infection after total hip arthroplasty. Past, present and future. J Bone Joint Surg, 77A: 1576-1588, 1995.
33. Garvin, KL; Evans, BG; Salvati, EA, y Brause, BD: Palacos gentamicin for the treatment of deep periprosthetic hip infections. Clin Orthop, 298: 97-105, 1994.
34. Garvin, KL; Fitzgerald, RH, y Salvati, E: Reconstruction of the infected total hip arthroplasty with gentamicin-impregnated Palacos bone cement En AAOS Instruct Course Lee, 42 293-302, 1993.
35. Goulet, JA; Pellicci, PM; Brause, BD, y Salvati, EM: Prolonged suppression of infection in total hip arthroplasty. J Arthroplasty, 3: 109-116, 1988.
36. Grauer, JD; Amstutz, HC; O'Carroll, PF, y Dorey, FJ: Resection arthroplasty ofthe hip. J Bone Joint Surg, 71 A: 669-678, 1989
37. Gristina, AG, y Costerton, JW: Bacterial adherence to biomatenals and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg. 67A: 264-273, 1985.
38. Gustilo, RB, y Tsukayama, D: Treatment of infected cemented total hip arthroplasty with tobramycin beads and delayed revision with a cementless prosthesis and bone grafting. Orthop Trans, 12: 739-745, 1988.
39. Hanssen, AD, y Osman, DR: Prevention of deep wound infection after total hip arroplasty: The role of prophylactic antibiotics and air clean technology. Sem Arthroplasty, 5: 114-121, 1994.
40. Harle, A: Infection management in total hip replacement. Arch Orthop Trauma Surg, 108: 63-71, 1989.
41. Harris, WH: One-stage exchange arthroplasty for septic total hip replacement. AAOS Instruct Course Lect, 35: 226-228, 1986.
42. Heydemann, JS, y Nelson, CL: Short-term preventive antibiotics. Clin Ortop, 205: 184-187, 1986.
43. Hill, C; Flamant, R; Maas, E, y Evrard, J: Prophylactic cefazolin versus placebo in total hip replacement. Report of multicentre double-blind randomized trial. Lancet, 1: 795-796, 1981.
44. Hope, PG; Kristinsson, KG; Norman, P, y Elson, RA: Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg, 71B: 851-855, 1989.
45. Hunter, G: The natural history of the patient with an infected total hip replacement. J Bone Joint Surg, 59B: 293-297, 1977.
46. Ivarsson, I; Wahlström, O; Djerf, K, y Jacobsson, SA: Revision of infected hip replacement. Two stage procedure with a temporary gentamicin spacer. Acta Orthop Scand, 65: 7-8, 1994.
47. Jacobson, JJ; Milard, HD; Plezia, R, y Blankenship, JR: Dental treatment and late prosthetic joint infections. Oral Surg Oral Med Oral Pathol, 61: 413-417, 1986.
48. James, ETR: Total hip revision arthroplasty Does sepsis influence the results? Clin Orthop, 170: 88-94, 1982.
49. Kaiser, AB: Antimicrobial prophylaxis in surgery. New England J Med, 315: 1129-1138, 1986.
50. Kantor, GS; Osterkamp, JA; Dorr, LD; Fischer, D; Perry, J, y Conaty, JP: Resection arthroplasty following infected total hip replacement arthroplasty. J Arthroplasty, 1: 83-89, 1986.
51. Katz, RP; Callaghan, JJ, y Johnston, RC: A minimum ten years follow-up study of one stage reimplantation of the infected total hip. Orthop Trans 18: 993, 1994-1995.
52. Levitsky, KA; Hozak, WJ, y Balderston, RA: Evaluation of the painful prosthetic joint. Relative value of bone scan, sedimentation rate, and joint aspiration. J Arthroplasty, 6: 237, 1991.
53. Lidwell, OM: Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: A randomized study. Br Med J, 285: 10-14, 1982.
54. Lidwell, OM: Ultraclean air and antibiotics for prevention of postoperative infection; a multicentre study of 8,052 joint replacement operations. Acta Orthop Scand, 58: 4-13, 1987
55. Lieberman, JR; Callaway, GH, y Salvati, EA: Treatment of the infected total hip arthroplasty with a two stage reimplantation protocol. Clin Orthop, 301: 205-212, 1994.
56. Lieberman, JR; Huo, MH; Schneider, R, y Salvati, EA: Evaluation of painful hip arthroplasties. Are technetium bone scans necessary? J Bone Joint Surg, 75B: 475-478, 1993.
57. Lortat, A: Antibiotic prophylaxis in orthopedic surgery. Ann F Anesth Reanim, 13 (5 suppl): 551-560, 1994.
58. Maderazo, EG; Judson, S, y Pasternak, H: Late infection of total joint prostheses. A review and recommendations for prevention. Clin Orthop, 229: 131-142, 1988.
59. Marotte, JH; Lord, GA; Blanchard, JP; Guillamon, JL; Samuel, P; Servant, JP, y Mercier, PH: Infection rate in total hip arthroplasty as a function of air cleanliness and antibiotic prophylaxis, 10-years experience with 2,384 cementless lord madreporic prostheses. J Arthroplasty, 2: 77-82, 1987.
60. Mauerhan, DR; Nelson, CL; Smith, DL, Fitzgerald, RH; Slama, TG; Petty, RW; Jones, RE, y Evans, RP: Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. J Bone Joint Surg, 76A: 3945, 1994.
61. McDonald, DJ; Fitzgerald, RH, Jr, y Ilstrup, DM: Two-stage reconstruction of a total hip arroplasty because of infection. J Bone Joint Surg, 71A: 828-834, 1989.
62. Menon, TJ: Chamley low friction arthoplasty in diabetic patients. J Bone Joint Surg, 65B: 580-581, 1983.
63. Menon, TJ: Chamley low friction arthroplasty in patients with psoriasis. Clin Orthop, 176: 127-128, 1983.
64. Merkel, KD; Brown, ML; Dewanjee, MK, y Fitzgerald, RH, Jr: Comparison of indium-labeled-leukocyte imaging with sequential technetium-gallium scanning in the diagnosis of low-grade musculoskeletal sepsis. A prospective study. J Bone Joint Surg, 67A: 465-476, 1985.
65. Moeckel, B; Huo, MH; Salvati, EA, y Pellici, PM: Total hip arroplasty in patients diabetes mellitus. J Arthroplasty, 8: 279-284, 1993.
66. Morscher, E: Management of infected hip arthroplasty. Orthopedics Internacional Edition, 3: 343-351, 1995.
67. Morscher, E: Treatment of infected joint arthroplasty. Int Orthop, 14: 161-165, 1990.
68. Nelson, CL: Prevention of sepsis. Clin Orthop, 222: 66-72, 1987.
69. Norden, CW: A critical review of antibiotic prophylaxis in orthopedic surgery. Rev Infect Dis, 5: 928-932, 1983.
70. Pratt, WB: Nutritional status of orthopedic patients with surgical complications. Clin Orthop, 155: 81-84, 1981.
71. Raut, VV; Siney, PD, y Wroblewski, BM: One-stage revision of infected total hip replacements with discharging sinuses J Bone Joint Surg, 76B: 721-724, 1994.
72. Röttger, J: Symposium antibiotic-impregnated acrylic composites. Contemp Orthop, 12: 85-135, 1986.
73. Rubin, R; Salvati, EA, y Lewis, R: Infected total hip replacement after dental procedures. Oral Surg, Oral Med, Oral Pathol, 40: 18-23, 1976.
74. Salvati, EA: Reimplantation in infection. A 12-year experience. Clin Orthop, 170: 62-75, 1982.
75. Salvati, EA; Robinson, RP; Zeno, SM; Koslin, BL; Brause, BD, y Wilson, PD: Infection rates after 3,715 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J Bone Joint Surg, 64A: 525-535, 1982.
76. Sanzen, L; Carlsson, AS; Josefsson, G, y Lindberg, LT: Revision operations on infected total hip arthroplasties. Two to nine-year follow up study. Clin Orthop, 229: 165-172, 1988.
77. Saxer, U: Infection problems in patients with endoprosthesis. Proceedings II World Congress Antisepsis. Norwalk, 1980: 99-100.
78. Schmalzried, TP: Incidence of deep sepsis in total hip arthroplasty. Survivorship analysis over 17 years from one hospital. J Arthroplasty, 6 (suppl): 47-51, 1991.
79. Schull, HJ, Jr; Greene, BM; Allen, SD; Dunn, GD, y Schenker, S: Bacteriemia with upper gastrointestinal endoscopy. Ann Intern Med, 83: 212-214, 1975.
80. Schutzer, SF, y Harris, WH: Deep-wound infection after total hip replacement under contemporary aseptic conditions. J Bone Joint Surg, 70A: 724-727, 1988.
81. Shih, L-Y; Wu, J-J, y Yang, D-J: Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop, 225: 238-246, 1987.
82. Stern, SH; Insall, JN; Windsor, RE; Inglis AE, y Dines, DM: Total knee arthroplasty in patients with psoriasis. Clin Orthop, 248: 108-111, 1989.
83. Stinchfield, FE; Bigliani, LU; Neu, HC; Goss, TP, y Foster, CR: Late haematogenous infection of total hip replacement. J Bone Joint Surg, 62A: 1345-1350, 1980.
84. Sullivan, PM; Johnston, RC, y Kelley, SS: Late infection after total hip replacement caused by an oral organism after dental manipulation. A case report. J Bone Joint Surg, 71A: 121-123, 1990
85. Ure, KJ; Amstutz, HC; Nasser, S, y Schmalzried, TP: Direct-exchange arthroplasty for the treatment of infection after total hip replacement. J Bone Joint Surg, 80A: 961-968, 1998.
86. Vanderhooft, E, y Robinson, RP: Late infection of a bipolar prosthesis following endoscopy. J Bone Joint Surg, 76A: 744-746, 1994.
87. Widmer, AF; Gaechter, A, y Oschsner, PE: Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infec Dis, 14: 1251-1253, 1992.
88. Wright, TM; Sullivan, DJ, y Arnoczky, SP: The effect of antibiotic additions on the fracture properties of bone cement. Acta Orthop Scand, 55: 414-418, 1984.
89. Wroblewski, BM, y Del Sel, HJ: Urethral instrumentation and deep sepsis in total hip replacement. Clin Orthop, 146: 209-212, 1980.
90. Wroblewski, BM: One-stage revision of infected cemented total hip arthroplasty. Clin Orthop, 211: 103-107, 1986
91. Wymenga, AB: Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations. Acta Orthop Scand, 63: 665-671, 1992.